Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines.
作者信息
Doherty Taylor A, Broide David H
机构信息
Department of Medicine, University of California, San Diego, San Diego, Calif.
Department of Medicine, University of California, San Diego, San Diego, Calif.
出版信息
J Allergy Clin Immunol. 2018 May;141(5):1587-1589. doi: 10.1016/j.jaci.2018.02.034. Epub 2018 Mar 6.
Abstract
摘要
相似文献
1
Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines.
J Allergy Clin Immunol. 2018 May;141(5):1587-1589. doi: 10.1016/j.jaci.2018.02.034. Epub 2018 Mar 6.
2
Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.
Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):38-45. doi: 10.1097/ACI.0000000000000498.
3
Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis.
Am J Rhinol Allergy. 2018 Jan 1;32(1):7-11. doi: 10.2500/ajra.2018.32.4498.
4
Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
J Immunol. 2015 Oct 15;195(8):3537-45. doi: 10.4049/jimmunol.1500905. Epub 2015 Sep 4.
5
Prostaglandin E Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling.
Front Immunol. 2018 Mar 12;9:501. doi: 10.3389/fimmu.2018.00501. eCollection 2018.
6
Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
J Immunol. 2018 Feb 1;200(3):915-927. doi: 10.4049/jimmunol.1700603. Epub 2017 Dec 27.
7
Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2017 Jul;140(1):101-108.e3. doi: 10.1016/j.jaci.2016.11.023. Epub 2017 Mar 6.
8
Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease.
J Allergy Clin Immunol. 2017 Mar;139(3):764-766. doi: 10.1016/j.jaci.2016.09.025. Epub 2016 Oct 19.
9
Eosinophil production of prostaglandin D in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2016 Oct;138(4):1089-1097.e3. doi: 10.1016/j.jaci.2016.04.042. Epub 2016 Jun 14.
10
Unraveling the complexity of leukotriene and prostaglandin inflammatory signaling.
J Allergy Clin Immunol. 2016 Jan;137(1):299-300. doi: 10.1016/j.jaci.2015.09.003. Epub 2015 Oct 27.
引用本文的文献
1
Fine-tuning ILC2s: CD48 Pumps Up the Volume.
Am J Respir Cell Mol Biol. 2025 Jul 30. doi: 10.1165/rcmb.2025-0381ED.
2
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell.
Immunol Rev. 2025 Mar;330(1):e70010. doi: 10.1111/imr.70010.
3
Modulating ILC2 function for treatment of type 2 airway diseases.
Curr Trends Immunol. 2022;23:85-90.
4
Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy.
Front Immunol. 2023 Feb 16;14:1115083. doi: 10.3389/fimmu.2023.1115083. eCollection 2023.
5
RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R.
Nat Commun. 2022 Jul 30;13(1):4435. doi: 10.1038/s41467-022-32176-5.
6
Discovering metabolite quantitative trait loci in asthma using an isolated population.
J Allergy Clin Immunol. 2022 May;149(5):1807-1811.e16. doi: 10.1016/j.jaci.2021.11.002. Epub 2021 Nov 12.
7
Tissue-Specific Molecular Markers and Heterogeneity in Type 2 Innate Lymphoid Cells.
Front Immunol. 2021 Oct 25;12:757967. doi: 10.3389/fimmu.2021.757967. eCollection 2021.
8
Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions.
Eur J Immunol. 2021 Oct;51(10):2399-2416. doi: 10.1002/eji.202048909. Epub 2021 Sep 7.
9
Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2021 Aug;148(2):309-318. doi: 10.1016/j.jaci.2021.06.016.
10
Purification and characterisation of the dimeric group 12 allergen from Blomia tropicalis heterologously expressed by Escherichia coli Top10F´.
Mol Biol Rep. 2021 Apr;48(4):3405-3416. doi: 10.1007/s11033-021-06361-6. Epub 2021 Apr 29.
本文引用的文献
1
Prostaglandin E suppresses human group 2 innate lymphoid cell function.
J Allergy Clin Immunol. 2018 May;141(5):1761-1773.e6. doi: 10.1016/j.jaci.2017.09.050. Epub 2017 Dec 5.
2
Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation.
Cell Rep. 2017 Nov 28;21(9):2487-2499. doi: 10.1016/j.celrep.2017.10.110.
3
Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.
J Cytokine Biol. 2017 Aug;2(2). doi: 10.4172/2576-3881.1000116. Epub 2017 Aug 4.
4
Sex Differences in Asthma: A Key Role of Androgen-Signaling in Group 2 Innate Lymphoid Cells.
Front Immunol. 2017 Aug 31;8:1069. doi: 10.3389/fimmu.2017.01069. eCollection 2017.
5
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.
J Clin Invest. 2017 Aug 1;127(8):3167-3176. doi: 10.1172/JCI92885. Epub 2017 Jul 24.
6
Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
J Immunol. 2017 Aug 1;199(3):1096-1104. doi: 10.4049/jimmunol.1601569. Epub 2017 Jun 30.
7
Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2017 Jul;140(1):101-108.e3. doi: 10.1016/j.jaci.2016.11.023. Epub 2017 Mar 6.
8
Update on Aspirin-Exacerbated Respiratory Disease.
Curr Allergy Asthma Rep. 2017 Jan;17(1):2. doi: 10.1007/s11882-017-0673-6.
9
Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.
J Exp Med. 2017 Jan;214(1):27-37. doi: 10.1084/jem.20161274. Epub 2016 Dec 23.
10
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.
Curr Allergy Asthma Rep. 2016 Jul;16(7):48. doi: 10.1007/s11882-016-0628-3.
Zotero 插件